- Home
- JAZZ vs SAIA Comparison
JAZZ vs SAIA Comparison
Compare JAZZ & SAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- SAIA
- Stock Information
- Founded
- JAZZ 2003
- SAIA 1924
- Country
- JAZZ Ireland
- SAIA United States
- Employees
- JAZZ N/A
- SAIA N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- SAIA Trucking Freight/Courier Services
- Sector
- JAZZ Health Care
- SAIA Industrials
- Exchange
- JAZZ Nasdaq
- SAIA Nasdaq
- Market Cap
- JAZZ 6.7B
- SAIA 7.6B
- IPO Year
- JAZZ 2007
- SAIA 2002
- Fundamental
- Price
- JAZZ $110.27
- SAIA $302.65
- Analyst Decision
- JAZZ Strong Buy
- SAIA Buy
- Analyst Count
- JAZZ 12
- SAIA 18
- Target Price
- JAZZ $183.08
- SAIA $375.94
- AVG Volume (30 Days)
- JAZZ 651.1K
- SAIA 629.6K
- Earning Date
- JAZZ 07-30-2025
- SAIA 07-25-2025
- Dividend Yield
- JAZZ N/A
- SAIA N/A
- EPS Growth
- JAZZ 49.21
- SAIA N/A
- EPS
- JAZZ 7.51
- SAIA 11.99
- Revenue
- JAZZ $4,064,808,000.00
- SAIA $3,241,874,000.00
- Revenue This Year
- JAZZ $6.05
- SAIA $3.18
- Revenue Next Year
- JAZZ $4.68
- SAIA $7.34
- P/E Ratio
- JAZZ $14.72
- SAIA $25.28
- Revenue Growth
- JAZZ 5.76
- SAIA 8.95
- 52 Week Low
- JAZZ $95.49
- SAIA $229.12
- 52 Week High
- JAZZ $148.06
- SAIA $624.55
- Technical
- Relative Strength Index (RSI)
- JAZZ 52.75
- SAIA 63.14
- Support Level
- JAZZ $109.27
- SAIA $283.03
- Resistance Level
- JAZZ $112.70
- SAIA $313.52
- Average True Range (ATR)
- JAZZ 2.72
- SAIA 10.66
- MACD
- JAZZ 0.42
- SAIA 3.87
- Stochastic Oscillator
- JAZZ 67.81
- SAIA 81.79
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About SAIA Saia Inc.
Saia ranks among the 10 largest less-than-truckload carriers in the United States, with more than 200 facilities and a fleet of more than 6,500 tractors and 26,000 trailers. As a national LTL carrier, the firm offers time-definite and expedited options for shipments ranging between 100 and 10,000 pounds. Saia ranks among the top-tier providers in terms of profitability.